top of page

Ionis Pharmaceuticals' CEO Brett Monia discusses the recent trial success of olezarsen in severe hypertriglyceridemia, the approval of Dawnzera in HAE, and more

  • Sep 8, 2025
  • 1 min read

He describes the significance of the olezarsen trial success in this patient population, and next steps. Plus, how Dawnzera might compete against other medicines in the HAE space, and pipeline programs to watch.




Coverage brought to you by:


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page